1. Home
  2. ADTN vs AMPH Comparison

ADTN vs AMPH Comparison

Compare ADTN & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADTRAN Holdings Inc.

ADTN

ADTRAN Holdings Inc.

HOLD

Current Price

$16.68

Market Cap

1.2B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.72

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADTN
AMPH
Founded
1985
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
971.8M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
ADTN
AMPH
Price
$16.68
$18.72
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$15.50
$28.38
AVG Volume (30 Days)
2.7M
710.6K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
90.83
N/A
EPS
N/A
0.14
Revenue
$1,083,807,000.00
$719,887,000.00
Revenue This Year
$11.09
$6.90
Revenue Next Year
$8.47
$4.64
P/E Ratio
N/A
$137.93
Revenue Growth
17.46
N/A
52 Week Low
$7.11
$16.65
52 Week High
$19.98
$31.26

Technical Indicators

Market Signals
Indicator
ADTN
AMPH
Relative Strength Index (RSI) 53.96 44.87
Support Level $8.45 $16.84
Resistance Level $18.34 $20.08
Average True Range (ATR) 1.14 0.80
MACD 0.15 0.11
Stochastic Oscillator 43.03 73.53

Price Performance

Historical Comparison
ADTN
AMPH

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: